Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (4): 360-363.doi: 10.35541/cjd.20190920
• Reviews • Previous Articles Next Articles
Li Jian, Song Zhiqiang
Received:
2019-09-23
Revised:
2020-06-04
Online:
2021-04-15
Published:
2021-03-31
Contact:
Song Zhiqiang
E-mail:zhiqiang.song@hotmail.com
Supported by:
Li Jian, Song Zhiqiang. New insights into facial flushing and erythema in rosacea[J]. Chinese Journal of Dermatology, 2021, 54(4): 360-363.doi:10.35541/cjd.20190920
[1] | Rueda LJ, Motta A, Pabón JG, et al. Epidemiology of rosacea in Colombia[J]. Int J Dermatol, 2017,56(5):510⁃513. doi: 10. 1111/ijd.13491. |
[2] | Johnston SA, Krasuska M, Millings A, et al. Experiences of rosacea and its treatment: an interpretative phenomenological analysis[J]. Br J Dermatol, 2018,178(1):154⁃160. doi: 10.1111/bjd.15780. |
[3] | Tan J, Steinhoff M, Berg M, et al. Shortcomings in rosacea diagnosis and classification[J]. Br J Dermatol, 2017,176(1):197⁃199. doi: 10.1111/bjd.14819. |
[4] | Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel[J]. Br J Dermatol, 2017,176(2):431⁃438. doi: 10.1111/bjd.15122. |
[5] | Forero Molina MA, Garcia E, Gonzalez⁃Devia D, et al. A 17⁃year⁃old male with a small bowel neuroendocrine tumor: flushing differential diagnosis[J]. World Allergy Organ J, 2017,10(1):30. doi: 10.1186/s40413⁃017⁃0161⁃4. |
[6] | Sadeghian A, Rouhana H, Oswald⁃Stumpf B, et al. Etiologies and management of cutaneous flushing: nonmalignant causes[J]. J Am Acad Dermatol, 2017,77(3):391⁃402. doi: 10.1016/j.jaad.2016.12.031. |
[7] | Loprinzi CL, Sloan J, Stearns V, et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis[J]. J Clin Oncol, 2009,27(17):2831⁃2837. doi: 10. 1200/JCO.2008.19.6253. |
[8] | Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update[J]. J Am Acad Dermatol, 2018,78(4):786⁃792.e8. doi: 10.1016/j.jaad.2017.09.016. |
[9] | Egeberg A, Ashina M, Gaist D, et al. Prevalence and risk of migraine in patients with rosacea: a population⁃based cohort study[J]. J Am Acad Dermatol, 2017,76(3):454⁃458. doi: 10. 1016/j.jaad.2016.08.055. |
[10] | Egeberg A, Hansen PR, Gislason GH, et al. Patients with rosacea have increased risk of depression and anxiety disorders: a danish nationwide cohort study[J]. Dermatology, 2016,232(2):208⁃213. doi: 10.1159/000444082. |
[11] | Scharschmidt TC, Yost JM, Truong SV, et al. Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment[J]. Arch Dermatol, 2011,147(1):123⁃126. doi: 10.1001/archdermatol.2010.413. |
[12] | Schaller M, Almeida LM, Bewley A, et al. Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel[J]. Br J Dermatol, 2017,176(2):465⁃471. doi: 10.1111/bjd.15173. |
[13] | Anzengruber F, Czernielewski J, Conrad C, et al. Swiss S1 guideline for the treatment of rosacea[J]. J Eur Acad Dermatol Venereol, 2017,31(11):1775⁃1791. doi: 10.1111/jdv.14349. |
[14] | Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase Ⅲ clinical trials evaluating anti⁃inflammatory dose doxycycline (40⁃mg doxycycline, USP capsules) administered once daily for treatment of rosacea[J]. J Am Acad Dermatol, 2007,56(5):791⁃802. doi: 10.1016/j.jaad.2006.11.021. |
[15] | Park JM, Mun JH, Song M, et al. Propranolol, doxycycline and combination therapy for the treatment of rosacea[J]. J Dermatol, 2015,42(1):64⁃69. doi: 10.1111/1346⁃8138.12687. |
[16] | van der Linden M, van Ratingen AR, van Rappard DC, et al. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single⁃blinded, noninferiority trial, comparing efficacy and safety[J]. Br J Dermatol, 2017,176(6):1465⁃1474. doi: 10.1111/bjd.15155. |
[17] | Two AM. Minocycline as an alternative to doxycycline in the treatment of rosacea[J]. Br J Dermatol, 2017,176(6):1426. doi: 10.1111/bjd.15514. |
[18] | Uslu M, Şavk E, Karaman G, et al. Rosacea treatment with intermediate⁃dose isotretinoin: follow⁃up with erythema and sebum measurements[J]. Acta Derm Venereol, 2012,92(1):73⁃77. doi: 10.2340/00015555⁃1204. |
[19] | van Zuuren EJ, Fedorowicz Z, Tan J, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments[J]. Br J Dermatol, 2019,181(1):65⁃79. doi: 10.1111/bjd.17590. |
[20] | Asai Y, Tan J, Baibergenova A, et al. Canadian clinical practice guidelines for rosacea[J]. J Cutan Med Surg, 2016,20(5):432⁃445. doi: 10.1177/1203475416650427. |
[21] | Two AM, Wu W, Gallo RL, et al. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors[J]. J Am Acad Dermatol, 2015,72(5):749⁃760. doi: 10.1016/j.jaad. 2014.08.028. |
[22] | Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation[J]. J Investig Dermatol Symp Proc, 2011,15(1):33⁃39. doi: 10.1038/jidsymp.2011.8. |
[23] | Gilman SE, Trinh NH, Smoller JW, et al. Psychosocial stressors and the prognosis of major depression: a test of Axis IV[J]. Psychol Med, 2013,43(2):303⁃316. doi: 10.1017/S0033291712 001080. |
[24] | Weber MD, Godbout JP, Sheridan JF. Repeated social defeat, neuroinflammation, and behavior: monocytes carry the signal[J]. Neuropsychopharmacology, 2017,42(1):46⁃61. doi: 10.1038/ npp.2016.102. |
[25] | Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases(review)[J]. Mol Med Rep, 2016,13(4):3391⁃3396. doi: 10.3892/mmr.2016.4948. |
[26] | Vidal Yucha SE, Tamamoto KA, Kaplan DL. The importance of the neuro⁃immuno⁃cutaneous system on human skin equivalent design[J]. Cell Prolif, 2019,52(6):e12677. doi: 10.1111/cpr. 12677. |
[27] | Hinwood M, Tynan RJ, Charnley JL, et al. Chronic stress induced remodeling of the prefrontal cortex: structural re⁃organization of microglia and the inhibitory effect of minocycline[J]. Cereb Cortex, 2013,23(8):1784⁃1797. doi: 10.1093/cercor/bhs151. |
[28] | Pietschke K, Schaller M. Long⁃term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol[J]. J Dermatolog Treat, 2018,29(3):310⁃313. doi: 10.1080/09546634.2017.1360991. |
[29] | Hsu CC, Lee JY. Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective β⁃adrenergic blocker[J]. J Am Acad Dermatol, 2012,67(3):491⁃493. doi: 10.1016/j.jaad.2012.04.017. |
[30] | Weihe E, Schütz B, Hartschuh W, et al. Coexpression of cholinergic and noradrenergic phenotypes in human and nonhuman autonomic nervous system[J]. J Comp Neurol, 2005,492(3):370⁃379. doi: 10.1002/cne.20745. |
[1] | Luo Shuaihantian, Long Hai, Lu Qianjin, . Research advances in systemic lupus erythematosus in 2023 [J]. Chinese Journal of Dermatology, 2024, 57(5): 468-471. |
[2] | Zhang Yuanwen, Sun Congqian, Pan Wendong. Off-label clinical application of botulinum toxin in dermatology [J]. Chinese Journal of Dermatology, 2024, 57(5): 471-475. |
[3] | Wang Shan, Jiao Lei, Liu Ying, Zhao Mutong, Shen Chunping, Xiao Yuanyuan, Li Li, Liang Yuan, Tian Jing, Wang Yang, Ma Lin. Protective effects of a sunscreen lotion containing Calendula extracts on children′s skin after sun exposure: a single-center, randomized, parallel controlled clinical study [J]. Chinese Journal of Dermatology, 2024, 0(4): 20230464-e20230464. |
[4] | Chen Xingyu, Yao Xu. Role of neutrophils in inflammatory dermatoses [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220865-e20220865. |
[5] | Pan Ruoxin, Gu Duoduo, Zhang Yue, Li Min, Tao Meng, Xu Yang. Metabolomics in rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 178-181. |
[6] | Wei Ziyu, Yang Yong. Role of ion channels in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 174-177. |
[7] | Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190. |
[8] | Li Ji, Xie Hongfu. How to avoid misdiagnosis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 119-122. |
[9] | Jiang Xian, Song Deyu. Insights into rosacea from the perspective of psychosomatic medicine [J]. Chinese Journal of Dermatology, 2024, 57(2): 123-126. |
[10] | Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status [J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133. |
[11] | Ma Guangrong, Xie Hongfu, Liu Jiashuang, Zhou Zhonglian, Zou Songqi, Huang Yingxue, Li Ji. Small intestinal bacterial overgrowth in patients with rosacea: prevalence and clinical features [J]. Chinese Journal of Dermatology, 2024, 57(2): 134-140. |
[12] | Hua You, Ren Haiyan, Song Xiuzu. Dermoscopic and reflectance confocal microscopic characteristics of five cases of erythema dyschromicum perstans [J]. Chinese Journal of Dermatology, 2024, 0(2): 20220827-e0220827. |
[13] | Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang. Severity assessment criteria for rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 182-185. |
[14] | Zhang Xiaodong, Wang Manya, Zhu Yingjie, Luo Tiande, Liu Xiaoming. Application of fluorescence staining in the detection of Demodex mites in the facial skin [J]. Chinese Journal of Dermatology, 2023, 56(8): 766-769. |
[15] | He Caifeng, Ci Chao, Lu Xiaohong, Yuan Tao, Yao Hui, Ji Yihuan, Wang Jun. Analysis of clinical and pathological features of 54 adult inpatients with erythema nodosum [J]. Chinese Journal of Dermatology, 2023, 56(7): 657-661. |
|